Sarpatwari A - Search Results

1

Trends in Use and Evidence of Adherence to Risk Evaluation and Mitigation Strategy Pregnancy Testing Requirements for Thalidomide, Lenalidomide, and Pomalidomide in the USA, 2000-2020.

Mahesri M, Sarpatwari A, Huybrechts KF, Lii J, Lee SB, Toyserkani GA, LaCivita C, Zhou EH, Dal Pan GJ, Kesselheim AS, Bykov K. Mahesri M, et al. Among authors: sarpatwari a. Drug Saf. 2024 Sep;47(9):909-919. doi: 10.1007/s40264-024-01443-3. Epub 2024 May 16. Drug Saf. 2024. PMID: 38755509

2

Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review.

Stasi R, Sarpatwari A, Segal JB, Osborn J, Evangelista ML, Cooper N, Provan D, Newland A, Amadori S, Bussel JB. Stasi R, et al. Among authors: sarpatwari a. Blood. 2009 Feb 5;113(6):1231-40. doi: 10.1182/blood-2008-07-167155. Epub 2008 Oct 22. Blood. 2009. PMID: 18945961 Free article. Review.

3

Thromboembolic events among adult patients with primary immune thrombocytopenia in the United Kingdom General Practice Research Database.

Sarpatwari A, Bennett D, Logie JW, Shukla A, Beach KJ, Newland AC, Sanderson S, Provan D. Sarpatwari A, et al. Haematologica. 2010 Jul;95(7):1167-75. doi: 10.3324/haematol.2009.018390. Epub 2010 Feb 9. Haematologica. 2010. PMID: 20145266 Free PMC article.

4

Using a drug-safety tool to prevent competition.

Sarpatwari A, Avorn J, Kesselheim AS. Sarpatwari A, et al. N Engl J Med. 2014 Apr 17;370(16):1476-8. doi: 10.1056/NEJMp1400488. N Engl J Med. 2014. PMID: 24738666 No abstract available.

5

Ensuring patient privacy in data sharing for postapproval research.

Sarpatwari A, Kesselheim AS, Malin BA, Gagne JJ, Schneeweiss S. Sarpatwari A, et al. N Engl J Med. 2014 Oct 23;371(17):1644-9. doi: 10.1056/NEJMsb1405487. N Engl J Med. 2014. PMID: 25337755 Free article. No abstract available.

6

Practical, legal, and ethical issues in expanded access to investigational drugs.

Darrow JJ, Sarpatwari A, Avorn J, Kesselheim AS. Darrow JJ, et al. Among authors: sarpatwari a. N Engl J Med. 2015 Jan 15;372(3):279-86. doi: 10.1056/NEJMhle1409465. N Engl J Med. 2015. PMID: 25587952 Free article. No abstract available.

7

Are risk evaluation and mitigation strategies associated with less off-label use of medications? The case of immune thrombocytopenia.

Sarpatwari A, Franklin JM, Avorn J, Seeger JD, Landon JE, Kesselheim AS. Sarpatwari A, et al. Clin Pharmacol Ther. 2015 Feb;97(2):186-93. doi: 10.1002/cpt.17. Epub 2014 Dec 20. Clin Pharmacol Ther. 2015. PMID: 25670524

8

Paying physicians to prescribe generic drugs and follow-on biologics in the United States.

Sarpatwari A, Choudhry NK, Avorn J, Kesselheim AS. Sarpatwari A, et al. PLoS Med. 2015 Mar 17;12(3):e1001802. doi: 10.1371/journal.pmed.1001802. eCollection 2015 Mar. PLoS Med. 2015. PMID: 25781468 Free PMC article.

9

Expanded access to investigational drugs.

Sarpatwari A, Darrow JJ, Kesselheim AS. Sarpatwari A, et al. N Engl J Med. 2015 Apr 9;372(15):1473-4. doi: 10.1056/NEJMc1501823. N Engl J Med. 2015. PMID: 25853762 No abstract available.

10

Progress and Hurdles for Follow-on Biologics.

Sarpatwari A, Avorn J, Kesselheim AS. Sarpatwari A, et al. N Engl J Med. 2015 Jun 18;372(25):2380-2. doi: 10.1056/NEJMp1504672. Epub 2015 May 6. N Engl J Med. 2015. PMID: 25946143 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

140 results

Search Page

Filters